Table 1.
Clinicopathological data of patients included in the sialyl-Tn (STn) analysis (n = 48).
| n (%) | |
|---|---|
| Stage | |
| I | 13 (27) |
| II | 11 (23) |
| III | 23 (48) |
| IV | 1 (2) |
| Tumour (pT) | |
| T1 | 9 (19) |
| T2 | 13 (27) |
| T3 | 25 (52) |
| T4 | 1 (2) |
| Lymph node metastasis (pN) | |
| N0 | 21 (44) |
| N1 | 11 (23) |
| N2 | 10 (21) |
| N3 | 6 (12) |
| Distant Metastasis (M) | |
| M0 | 47 (98) |
| M1 | 1 (2) |
| Distant Recurrence (DR) | |
| No | 31 (65) |
| Yes | 17 (35) |
| Histological Classification | |
| Squamous cell carcinoma | 48 (100) |
| Adenocarcinoma | 0 (0) |
| Keratinization Degree | |
| Non-keratinized | 30 (63) |
| Moderately keratinized | 2 (4) |
| Keratinized | 16 (33) |
| Differentiation Degree | |
| Well-differentiated | 7 (15) |
| Moderately differentiated | 26 (54) |
| Poorly differentiated | 10 (21) |
| Missing information | 5 (10) |
| Extra-tumoral growth | |
| Present | 12 (25) |
| Absent | 36 (75) |
| Lymphovascular Permeation | |
| Present | 21 (44) |
| Absent | 27 (56) |
| Neural Permeation | |
| Present | 13 (27) |
| Absent | 35 (73) |